Isu Abxis, Stock Price 10,050 Won (-13.36%)... Bulletin Board 'Bustling'
At this time, posts about Isu Abxis are rapidly increasing on portals and securities communities. Today, foreigners have tentatively sold a net 3,000 shares of Isu Abxis, and institutions have sold a net 33,000 shares. Isu Abxis is known as a subsidiary of the Isu Group, developing antibiotic treatments and providing medical services.
As of 1:30 PM on the 9th, the stock price of Isu Abxis is 10,050 KRW, down 13.36% from the previous day, with a trading volume of 3,809,360 shares, which is about 36.87% of the 5-day average trading volume. On March 5, Isu Abxis became a market issue with the news "Gaucher disease treatment Abcertin completes Phase 1 clinical trial... stock price rises."
In addition to Isu Abxis, posts by investors are rapidly increasing for Bident (121800), KTH (036030), and Baekkwang Industry (001340).
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- Tragedy Strikes on Part-time Job Commute... Man in His 30s Arrested for Drunk Driving Death of Freshman College Student
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
